Nolla Health announced on October 5, 2026, that its Nolla Derm mobile application has begun issuing AI-generated initial acne prescriptions to adult residents in Utah. Operating under a state regulatory sandbox agreement, the company is the first in the United States authorized by a state regulatory body to allow an AI system to issue an initial prescription rather than processing refills of existing medications.
A State-Supervised Regulatory Sandbox
The demonstration operates under a 12-month agreement between Utah's Office of Artificial Intelligence Policy, the Division of Professional Licensing, and Nolla Health operating entities Magic Health, Inc. and Magic Health Services, LLC. Under the terms, state licensing authorities will refrain from bringing enforcement actions regarding telehealth requirements or unlicensed practice for qualifying initial topical prescriptions and renewals generated by the software and sent to Utah-licensed pharmacists. Participating entities must submit monthly quantitative reports on patient volume, clinician agreement rates, and adverse events, alongside external audits conducted by state-vetted evaluators.
Strict Scope and Hard-Stop Safeguards
The pilot is restricted to Utah residents aged 18 and older at a promotional rate of $4.99 per month. Patients complete identity verification, an intake survey, and a five-angle facial photo intake that the AI uses to score acne severity via the Investigator Global Assessment scale. Prescribing authority is limited strictly to mild to moderate acne using a pre-approved list of topical treatments, including tretinoin, adapalene, clindamycin, benzoyl peroxide, azelaic acid, and specific compounded formulations. Built-in hard stops direct patients with severe acne, pregnancy, immunosuppression, organ disease, or prior drug reactions out of the automated flow and to human physicians.
Three-Stage Physician Oversight
The project implements a three-stage clinical oversight model to evaluate accuracy before granting broader automation. In stage one, running at least four weeks across the first 100 patients, two Utah-licensed physicians must independently review and approve every AI recommendation before a prescription is issued. Advancing to later stages—where the AI issues prescriptions directly subject to retrospective clinician audits—requires written state approval, zero uncaptured hard-stop failures, zero serious adverse events, and a minimum 95 percent agreement rate between the AI model and reviewing doctors.
AI-generated editorial illustration; not a documentary photograph.
Source: Nolla Health Launches AI-Issued Initial Acne Prescriptions in Utah
SIGNAL TITANS
Leave a Reply